APA (7th ed.) Citation

Burban, A., Tessier, C., Larroquette, M., Guyon, J., Lubiato, C., Pinglaut, M., . . . Sharanek, A. (2025). Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile. EMBO molecular medicine, 17(3), 469-503. https://doi.org/10.1038/s44321-025-00195-6

Chicago Style (17th ed.) Citation

Burban, Audrey, et al. "Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-penetrant Drug with a Safe Profile." EMBO Molecular Medicine 17, no. 3 (2025): 469-503. https://doi.org/10.1038/s44321-025-00195-6.

MLA (9th ed.) Citation

Burban, Audrey, et al. "Exploiting Metabolic Vulnerability in Glioblastoma Using a Brain-penetrant Drug with a Safe Profile." EMBO Molecular Medicine, vol. 17, no. 3, 2025, pp. 469-503, https://doi.org/10.1038/s44321-025-00195-6.